Similarly, AHNAK2, ARL4C, ASAP2 were all highly expressed in pancreatic cancers, correlated with KRAS G12D mutation and could predict survival in pancreatic cancers (Figure S3). The gene discussed is KRAS; the disease is familial pancreatic carcinoma.